Analysts Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) PT at $23.57
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 […]
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 […]
